Stocks to Sell

Stocks can plunge for any number of reasons — investors may need to raise cash for large milestone purchases, or algorithms could be triggered by stop losses which create massive selloffs. Whatever the case, InvestorPlace’s journalists weed out the markets’ losers, keeping you informed of which stocks to cash out of before they come crashing down.

Is Spotify Stock a Buy Ahead of Earnings? No.

By Stavros Georgiadis, CFA, InvestorPlace Contributor
Is SPOT stock a buy with less than a month before Spotify's next earnings report? Based on its valuation it is not, as it is very pricey.

Analysts Are Still Bearish on AMC Stock

By Stavros Georgiadis, CFA, InvestorPlace Contributor
"Meme stock madness" are three words which apply to AMC stock. It is still not a buy as the company transforms.

Don’t Let Shopify Stock Split News Tempt You Into Buying SHOP

By Joel Baglole, InvestorPlace Contributor
The Shopify stock split looks like another attempt to distract SHOP stock investors from ongoing problems like slowing growth.

SoFi Technologies Will Continue to Suffer, And Not Just From Paused Student Loans

By Alex Sirois, InvestorPlace Contributor
SOFI stock doesn't look good, and it's due to more than student loans. There are multiple factors holding it down.

Mullen Stock Faces Red Flag Issues with a New Hindenburg Research Report

By Mark R. Hake, CFA
Mullen Automotive stock faces red flag issues with a new Hindenburg Research short report. Avoid MULN stock as a huge percentage of its float is held short, especially now that Hindenburg's short report details its shortcomings.

Moderna’s Lot Recall Is a Blot Despite Its Recent 2nd Covid-19 Booster Approval

By Mark R. Hake, CFA
MRNA stock could get hurt from a recent recall in Moderna's Covid-19 vaccine, despite other recent good news from an EUA approval.

Elon Musk Can’t Change the Fundamental Value of Twitter. Don’t Buy In.

By Dana Blankenhorn, InvestorPlace Contributor
Twitter is still a money-losing social network trying to scrounge cash from users. Musk's move doesn't change the true value of TWTR stock.

Alibaba Remains Too Risky for Investors to Buy

By Joel Baglole, InvestorPlace Contributor
While BABA stock appears to have finally bottomed, the company continues to struggle with several ongoing issues.

EDU Stock Is Rocketing 850%. The Reason Is Not as Exciting as It May Seem.

By Cristian Docan
The virtual surge of EDU stock has not offset the hard regulatory hit it took last year. EDU is not a great investment for now.

Goldman Sachs Got it Right on Robinhood, Sell Your HOOD Stock Now

By Samed Olukoya
As long as Robinhood users continue to drop, weak revenue and the inability to turn profitable will continue to weigh on the outlook of HOOD stock.

Analyst Concerns Put More Pressure on Affirm

By Faizan Farooque, InvestorPlace Contributor
MoffettNathanson initiated coverage on AFRM stock with a neutral rating. They also announced their recommendation of a price target of $50.

Disney Is Having a Rough Year and It Has Been This Way for a Long Time

By Mark R. Hake, CFA
DIS stock has done poorly for years and its negative free cash flow, no dividend and no buybacks have unsettled the market's opinion.

Time to Take Profits on IMAC Stock After Shares Soar on Walmart News

By Faizan Farooque, InvestorPlace Contributor
It is time to sell your IMAC stock and make a nice profit on the recent rally because the company hasn't shown the ability to make profits.

Popular Short-Squeeze Target Newegg Tumbles. Sell NEGG Stock While You Can.

By Stavros Georgiadis, CFA, InvestorPlace Contributor
NEGG stock has experienced extremely volatile trading the past two days. Here's why the price action in Newegg will likely continue downward.

Citi Sees Roblox Running to $59. Should YOU Buy RBLX Stock Now?

By Samed Olukoya
RBLX stock has dropped 58% YTD on the back of rising interest rates and growing global uncertainty. It will remain subdued in the near term.

Vaccine Makers Down on FDA Meeting, Novavax Most at Risk

By Joseph Nograles
The major covid-19 vaccine makers are all down, anticipating bad-for-business news from the FDA. However, NVAX stock has the most to lose.

Norwegian Cruise Lines Stock Is Doing Well, But for How Long?

By GS Early
There's certainly enough reasons to root for NCLH stock to succeed, but sadly there's much less reason to buy it here.

Don’t Wish Upon ContextLogic’s Star

By Josh Enomoto, InvestorPlace Contributor
Although deeply embattled, WISH stock has printed some encouraging movements, but the fundamentals remain severely challenged.

Why Is Lucid Motors Down This Week?

By Vandita Jadeja
Lucid Motors is down due to the missed production targets and LCID stock is best avoided at the current level.
Load More Articles